ST. LOUIS--(BUSINESS WIRE)--The drug API Innovation Center today announced it has reached a milestone in the development of technology essential to accelerating the U.S. production of lomustine, a ...

Technological progressions to increase manufacturing capacity in API production offers higher market prospects in developed markets for specialty active pharmaceutical ingredients (API). Substantial ...